Heart surgery bleeding study: does paying for fibrinogen change transfusion habits?

NCT ID NCT07457879

Not yet recruiting Knowledge-focused Sponsor: Erasme University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether making fibrinogen concentrate (a protein that helps blood clot) free for hospitals in Belgium changed how doctors manage bleeding during complex heart surgery. Researchers will compare transfusion rates and patient outcomes before and after the reimbursement policy started in April 2020. About 450 adults having complex heart surgery at one hospital will be included, using data from 2016 to 2024.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could show that making fibrinogen concentrate available changes how doctors manage bleeding during heart surgery, potentially reducing blood transfusions.
What could go wrong: This is an observational study, not a controlled trial, so it can only show associations, not cause and effect. Results may be influenced by other changes in practice over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY

Contacts and locations

Locations

H.U.B - Hôpital Erasme

Brussels, 1070, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.